Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Isabel Lucena

Showing results (51-60 of 152) with videos related to

Pageof 16
Sort By:
Current Drug Metabolism|March 11, 2010
Pharmacogenomics in drug induced liver injuryRaúl J Andrade, José A G Agúndez, M Isabel Lucena, et al.
Expert Review of Clinical Pharmacology|January 16, 2014
Idiosyncratic drug hepatotoxicity: a 2008 updateRaúl J Andrade, Susana López-Ortega, M Carmen López-Vega, et al.
World Journal of Gastroenterology|January 19, 2007
Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologistsRaúl-J Andrade, Mercedes Robles, Alejandra Fernández-Castañer, et al.
Archives of Toxicology|March 5, 2021
Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approachAndres Gonzalez-Jimenez, Ayako Suzuki, Minjun Chen, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical PracticeMarina Villanueva-Paz, Laura Morán, Nuria López-Alcántara, et al.
Frontiers in Pharmacology|June 3, 2022
N-Acetylcysteine for the Management of Non-Acetaminophen Drug-Induced Liver Injury in Adults: A Systematic ReviewJudith Sanabria-Cabrera, Sara Tabbai, Hao Niu, et al.
World Journal of Gastroenterology|August 29, 2006
Adverse hepatic reactions associated with calcium carbimide and disulfiram therapy: is there still a role for these drugs?Carmen Verge, M Isabel Lucena, Enrique López-Torres, et al.
Drug Safety|July 25, 2016
Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future DirectionsMahmoud Slim, Inmaculada Medina-Caliz, Andres Gonzalez-Jimenez, et al.
Pharmacoepidemiology and Drug Safety|July 14, 2011
Continuous reporting of new cases in Spain supports the relationship between Herbalife® products and liver injuryGloria Manso, Laureano López-Rivas, M Esther Salgueiro, et al.
Current Pharmaceutical Design|November 8, 2019
Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary ApproachJudith Sanabria-Cabrera, Inmaculada Medina-Cáliz, Simona Stankevičiūtė, et al.
Pageof 16

Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Current Drug Metabolism|March 11, 2010
Pharmacogenomics in drug induced liver injuryRaúl J Andrade, José A G Agúndez, M Isabel Lucena, et al.
Expert Review of Clinical Pharmacology|January 16, 2014
Idiosyncratic drug hepatotoxicity: a 2008 updateRaúl J Andrade, Susana López-Ortega, M Carmen López-Vega, et al.
World Journal of Gastroenterology|January 19, 2007
Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologistsRaúl-J Andrade, Mercedes Robles, Alejandra Fernández-Castañer, et al.
Archives of Toxicology|March 5, 2021
Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approachAndres Gonzalez-Jimenez, Ayako Suzuki, Minjun Chen, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical PracticeMarina Villanueva-Paz, Laura Morán, Nuria López-Alcántara, et al.
Frontiers in Pharmacology|June 3, 2022
N-Acetylcysteine for the Management of Non-Acetaminophen Drug-Induced Liver Injury in Adults: A Systematic ReviewJudith Sanabria-Cabrera, Sara Tabbai, Hao Niu, et al.
World Journal of Gastroenterology|August 29, 2006
Adverse hepatic reactions associated with calcium carbimide and disulfiram therapy: is there still a role for these drugs?Carmen Verge, M Isabel Lucena, Enrique López-Torres, et al.
Drug Safety|July 25, 2016
Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future DirectionsMahmoud Slim, Inmaculada Medina-Caliz, Andres Gonzalez-Jimenez, et al.
Pharmacoepidemiology and Drug Safety|July 14, 2011
Continuous reporting of new cases in Spain supports the relationship between Herbalife® products and liver injuryGloria Manso, Laureano López-Rivas, M Esther Salgueiro, et al.
Current Pharmaceutical Design|November 8, 2019
Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary ApproachJudith Sanabria-Cabrera, Inmaculada Medina-Cáliz, Simona Stankevičiūtė, et al.
Pageof 16